Announced Wed, 15 Jul · 10:02 IST
Gujarat Inject Kerala Q1 FY27 results: EPS rises to Rs 1.28 vs Rs 0.86 YoY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹13.40
prior close
₹13.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1+0.0-1.1-0.4+0.0-4.9-5.2-9.7-14.2-14.9————
Up moveDown movePending
AI summary
Board approved unaudited Q1 FY27 results (quarter ended 30 June 2026). Basic and diluted EPS rose to Rs 1.28 from Rs 0.86 YoY, a jump of about 49 percent. Auditor S Mandawat and Co issued an unmodified limited review report with no qualifications. Company has only one reportable segment. Detailed revenue and PAT line items were not clearly legible in the filing.
Likely market impact
Strong 49 percent EPS growth and clean auditor report signal improved profitability; could be positive for the stock.